About HCI Cleaning Products
HCI Cleaning Products is a private company based in Hollis, New Hampshire, incorporated in 2026 in Delaware. It has reported $7,666,140 raised in eight offerings on Form D since August 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | Feb 13, 2026 | $85,000of $2.0M target | 2 | $42,500 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 16, 2022 | Mar 29, 2022 | $343,885of $5.0M target | 9 | $38,209 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 25, 2021 | Feb 3, 2021 | $705,577of $3.0M target | 13 | $54,275 | Equity, Debt, Options, Securities on exercise, Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| Feb 24, 2020 | Mar 9, 2020amended Apr 8, 2020 | $1,616,255of $3.5M target | 21 | $76,965 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 1, 2019 | Feb 12, 2019amended Jun 10, 2019 | $1,999,987fully sold | 33 | $60,606 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 28, 2017 | Oct 12, 2017amended Oct 5, 2018 | $2,152,936of $2.5M target | 35 | $61,512 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 9, 2017 | Jan 13, 2017 | $412,500of $1.0M target | 8 | $51,563 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 14, 2015 | Aug 27, 2015 | $350,000of $1.0M target | 4 | $87,500 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, eight offerings | $7,666,140 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on HCI Cleaning Products's Form D filed Feb 13, 2026.
Earlier filings also listed Stuart Flavin (executive officer and director, last listed Mar 2022), Sandy Posa (president and director, last listed Mar 2022), Trip Flavin (executive officer and director, last listed Jun 2019), Peter Clay (director, last listed Oct 2018) and Matthew Sutton (director, last listed Aug 2015).